)
Indivior (INDV) investor relations material
Indivior Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 2026 net revenue rose 13% YoY to $356M; record SUBLOCADE revenue reached $267M, up 22% YoY.
GAAP operating income increased to $180M from $43M and net income to $137M from $42M; adjusted EBITDA rose 76% to $211M.
Action Agenda execution continued ahead of the planned November 2 merger closing with Supernus.
Financial highlights
9M 2026 revenue rose 15% YoY to $1,016M; gross profit was $875M, operating income $477M and GAAP net income $348M.
Q3 GAAP diluted EPS was $1.12 versus $0.33; 9M GAAP diluted EPS was $2.78 versus $0.85.
Q3 non-GAAP net income was $161M ($1.32 diluted EPS); 9M non-GAAP net income was $427M ($3.41 diluted EPS).
GAAP operating expenses fell 33% YoY to $125M; non-GAAP operating expenses fell 29% to $103M.
9M operating cash flow rose to $317M from $194M; cash and equivalents were $305M at September 30, while cash and investments totaled $332M.
Outlook and guidance
Standalone FY 2026 guidance: revenue $1,295M–$1,365M; SUBLOCADE revenue $1,010M–$1,050M; non-GAAP operating expenses $430M–$450M; adjusted EBITDA $700M–$740M.
Guidance assumes no material change in key exchange rates versus 2025 averages; it ceases to apply if the merger closes November 2.
Rest-of-World revenue is expected to decline substantially after market exits; Q4 capex is expected to be $10M, primarily for the Raleigh facility.
Liquidity is expected to cover anticipated cash needs for at least 12 months, conditional on sustained sales and no material change in collections and rebate-payment timing.
- Merger-related share issuance approved; adjournment proposal was unnecessary.INDV
EGM 2026 - Merger forms a $2.2B CNS biopharma leader with strong growth, profitability, and synergies.INDV
Corporate presentation - Q2 2026 saw record results and a merger to form a CNS leader with $2.2B revenue and $888M EBITDA.INDV
Q2 2026 & Merger - SUBLOCADE's growth accelerates with DTC and commercial gains as diversification plans advance.INDV
Jefferies Global Healthcare Conference 2026 - All proposals, including director elections and auditor ratification, were approved.INDV
AGM 2026 - Q1 2026 delivered record EBITDA, 19% revenue growth, and raised guidance on SUBLOCADE strength.INDV
Q1 2026 - Strong financial results, U.S. redomicile, and robust governance mark a pivotal year.INDV
Proxy filing - SUBLOCADE growth, cost cuts, and organizational overhaul drive the 2025–2026 strategy.INDV
Morgan Stanley 23rd Annual Global Healthcare Conference - SUBLOCADE growth drove FY 2024 gains, but 2025 faces a 17% revenue decline from SUBOXONE Film erosion.INDV
Q4 2024
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)